Delivery Order SPE2DB20D2014-SPE2DB25FB11W

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,518.76 firm fixed-price delivery order is for Injectafer 750 mg/15 ml vials, with a period of performance through November 13, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,850.63, is for the delivery of Injectafer 750 mg/15 ml vials. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Injectafer 750 mg/15 ml vials. The contract has a firm fixed price of $3,217.98 and a period of performance through September 18, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which provides a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation. The contract, valued at $34,643.76, is for the delivery of Injectafer 750 mg/15 mL vials. It is a firm fixed-price delivery order contract with an ultimate completion date of August 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of Injectafer 750 mg/15 ml vial, a specialty pharmaceutical product. The $8,837.40 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several large Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,398.11 firm fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials, a specialty medication. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. The contract is not designated as a set-aside. It is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,286.89, is for the delivery of INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,632.25 firm fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials to support federal healthcare programs. The award is not associated with a set-aside designation, indicating open competition. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $9,341.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Injectafer 750 mg/15 ml vials, a specialty medication, to support military healthcare programs. This is an individual delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $17,086.15, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Injectafer 750 mg/15 ml vials. The contract has a firm fixed price and a completion date of June 18, 2024. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution giant Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the Department of...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB11W
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer 750 mg/15 ml vials. The $10,756 firm fixed-price contract has a completion date of February 20, 2025 and is not set aside.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/21/25, 9:59 AM